SpyGlass Pharma, Inc. (SGP) — Financial Flexibility Index
SpyGlass Pharma, Inc. (SGP) has a Financial Flexibility Index of -0.04x as of December 2025. Free cash flow of $-8.91 Million (operating CF $-9.33 Million minus capex $420.49K) represents 0% of total liabilities ($214.70 Million). Also explore SpyGlass Pharma, Inc. (SGP) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SpyGlass Pharma, Inc. Financial Flexibility Index (2023–2025)
Historical Financial Flexibility Index trend for SpyGlass Pharma, Inc. across 3 annual periods. Check SGP asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for SpyGlass Pharma, Inc. (2023–2025)
Year-by-year free cash flow to debt coverage for SpyGlass Pharma, Inc.. For the full company profile including market capitalisation, see SpyGlass Pharma, Inc. (SGP) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.15x | $-31.91 Million | $-32.70 Million | $214.70 Million | ▲ +37.8% |
| 2024 | -0.24x | $-20.04 Million | $-22.03 Million | $83.79 Million | ▼ -47.0% |
| 2023 | -0.16x | $-12.06 Million | $-12.28 Million | $74.13 Million | — |